A Shifting Paradigm

Electronic Data Capture and Clinical Trial Management are undergoing significant changes. Those changes are being driven by technologies such as Clinical Studio. Companies are shifting from overpriced, bloated and obsolete technologies that require an army of IT professionals, to modern, state of the art and cost effective technologies that require no IT professionals. The two main factors in this change are superior technology and significant cost savings. These two factors almost always go hand in hand.

The days are numbered for companies that cannot compete on a technology or cost basis. In fact, these companies provide all sorts of services that traditionally are provided by Clinical Research Organizations. The biggest reason these companies provide these services (study builds, SAS programming, monitoring, medical coding, etc), is that you need to have a computer science degree just to use these “features”. This phenomena, morphed technology companies into CROs. Oftentimes, CROs use these “technology companies”, thus funding their own competition.

Technologies like Clinical Studio allow Biotech companies to bring outsourced services in house. Clinical Studio allows Data Managers and other Clinical Professionals to rapidly build and deploy studies. This is giving the Biotech companies tremendous control over their studies. The results are much more favorable than the outsource and the cost savings are significant. How is this possible? Technology, or put another way, Superior Technology. If you can write a document in WORD you can build a CRF in Clinical Studio or write a report or create amazing graphics or deploy ePRO forms to patient’s mobile phones or manage inventory or auto-code medications and adverse events. Clinical Studio is about to announce their 1,000th study. That is a growth rate of over 900% in the last 18 months. That makes Clinical Studio the fastest growing and largest study platform in the world.

Beware to the CROs that are so comfortable with their success that they have no experience utilizing the modern tools of Clinical Studio to conduct studies. This Biotech industry shift from offshore outsource to internal study management using Clinical Studio is spreading fast. These companies will inevitably need CROs to quickly build, deploy and manage studies. The cost savings are so significant, that these companies can now conduct double the studies for the same price. The technology is so significant, that study durations are now being cut by a whopping 50%.

In 1980 the CP/M operating system scoffed at the growth rate of a little known OS called MS-DOS. Within 2 years, MS-DOS completed dominated the business landscape and had a near monopoly. Those companies that stayed on the CP/M platform are no longer around (do you use WORD or Word Star?). Technology changes quickly and it is the quick thinkers that have the staying power. Are you or your organization going to be left behind?